Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer
Authors
Keywords
-
Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume 19, Issue 1, Pages 1-6
Publisher
Springer Nature
Online
2015-06-30
DOI
10.1038/pcan.2015.31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
- (2015) P. Blume-Jensen et al. CLINICAL CANCER RESEARCH
- A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy
- (2015) Eric A. Klein et al. EUROPEAN UROLOGY
- Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer
- (2015) Anthony V. D'Amico JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy
- (2015) Robert B. Den et al. JOURNAL OF CLINICAL ONCOLOGY
- Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer
- (2015) Ridwan Alam et al. JOURNAL OF UROLOGY
- A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial
- (2014) Maria Pearse et al. BJU INTERNATIONAL
- Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
- (2014) M Shipitsin et al. BRITISH JOURNAL OF CANCER
- Abstract 1086: MYC overexpression combined with Pten loss generates genomic instability and rapid metastasis in a new mouse model of lethal prostate adenocarcinoma.
- (2014) Gretchen K. Hubbard et al. CANCER RESEARCH
- Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry
- (2014) E. David Crawford et al. CURRENT MEDICAL RESEARCH AND OPINION
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
- (2014) Robert B. Den et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
- (2014) Prabhakar Mithal et al. INTERNATIONAL JOURNAL OF UROLOGY
- Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2014) Stephen J. Freedland et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy
- (2014) Jay T. Bishoff et al. JOURNAL OF UROLOGY
- Prostate Cancer Ki-67 (MIB-1) Expression, Perineural Invasion, and Gleason Score as Biopsy-Based Predictors of Prostate Cancer Mortality: The Mayo Model
- (2014) Matthew K. Tollefson et al. MAYO CLINIC PROCEEDINGS
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- (2014) Tamara L Lotan et al. MODERN PATHOLOGY
- Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
- (2014) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
- (2014) Michail Shipitsin et al. Proteome Science
- ERG induces taxane resistance in castration-resistant prostate cancer
- (2014) Giuseppe Galletti et al. Nature Communications
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
- (2013) G Fisher et al. BRITISH JOURNAL OF CANCER
- Genetic markers associated with early cancer-specific mortality following prostatectomy
- (2013) Wennuan Liu et al. CANCER
- Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
- (2013) K. A. Leinonen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer
- (2013) Neal Shore et al. CURRENT MEDICAL RESEARCH AND OPINION
- Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
- (2013) Stephen J. Freedland et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
- (2013) R. Jeffrey Karnes et al. JOURNAL OF UROLOGY
- Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
- (2013) Ian M. Thompson et al. JOURNAL OF UROLOGY
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
- (2013) A E Ross et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
- (2012) Michel Bolla et al. LANCET
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
- (2011) Jeffrey J. Tosoian et al. JOURNAL OF CLINICAL ONCOLOGY
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
- (2010) Andrea B. Apolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
- (2010) Michael C Haffner et al. NATURE GENETICS
- MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
- (2009) Li-Yan Khor et al. JOURNAL OF CLINICAL ONCOLOGY
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started